GGrantIndex
Sort

10,766 grants matching checkpoint inhibitor

Arginine Availability, Modulated by MDSC, Regulates T Cell Function in Cancer

$242,442
Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2011 · CA

Arginine Availability, Modulated by MDSC, Regulates T Cell Function in Cancer

$242,442
Augusto C Ochoa · Lsu Health Sciences Center · R01 · FY2012 · CA

An RNA:DNA intermediate of LINE-1 retrotransposition - a novel trigger of cytotoxicity

$242,295
Alex Bortvin · Carnegie Institution Of Washington, D.C. · R21 · FY2017 · HD

Cyclin-dependent kinase inhibitor regulation during the Xenopus cell cycle

$242,260
P. Renee Yew · University Of Texas Hlth Science Center · R01 · FY2007 · GM

Cyclin-dependent kinase inhibitor regulation during the Xenopus cell cycle

$242,260
P. Renee Yew · University Of Texas Hlth Science Center · R01 · FY2008 · GM

Project 3: HHLA2 as a THerapeutic Target in RCC

$241,930
David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2024 · CA

Project 3: HHLA2 as a THerapeutic Target in RCC

$241,778
David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2023 · CA

The DNA Damage Response as a therapeutic target in BK virus nephropathy

$241,777
Thomas David Friedrich · Albany Medical College · R21 · FY2012 · AI

Measuring and manipulating metabolic fluxes in the tumor microenvironment

$241,765
Caroline Bartman · University Of Pennsylvania · R00 · FY2024 · CA

Transcriptional silencing by the BCL6 oncoprotein

$241,708
Ari M. Melnick · Weill Medical Coll Of Cornell Univ · R01 · FY2014 · CA

MODULATION OF HOST CELL APOPTOTIC RESPONSES BY HPVE7

$241,559
Harvard University (Medical School) · R01 · FY2000 · CA

TET2 Regulation of CD8 T cell differentiation During Chronic Viral Infection

$241,500
Martha S Jordan · University Of Pennsylvania · R21 · FY2019 · AI

Res Proj 2: Molecular Imaging Strategies to Study Cdc25A Regulation in vivo

$241,335
Helen M Piwnica-Worms · Washington University · P50 · FY2008 · CA

Structure Function Analysis of SML1

$241,063
University Of Tennessee Knoxville · R01 · FY2003 · CA

Structure Function Analysis of SML1

$241,063
University Of Tennessee Knoxville · R01 · FY2004 · CA

INTERACTION OF YEAST CHECKPOINT PROTEINS AS DRUG ASSAY

$241,041
Emory University · R01 · FY2000 · CA

In vivo CRISPR-screening of novel cancer cell-intrinsic targets that sensitize to local ionizing radiation, and possible combination with systemic checkpoint blockade.

$240,831
Ralph R Weichselbaum · University Of Chicago · R21 · FY2022 · CA

Target validation of CD206 activators

$240,788
Juan Marugan · National Center For Advancing Translational Sciences · ZIA · FY2023 · TR

G2 Checkpoint Function in Human Fibroblasts

$240,696
William K Kaufmann · Univ Of North Carolina Chapel Hill · R01 · FY2007 · CA

Mechanism of the Spindle Assembly Checkpoint Control

$240,638
Stanford University · R01 · FY2002 · GM

Project 3: Targeting Vulnerabilities in the Fibrotic Extracellular Matrix (ECM) of Lung Cancers

$240,614
Don Lynn Gibbons · Ut Southwestern Medical Center · P50 · FY2024 · CA

Metabolic regulation of epigenetic states in CD8 T cell exhaustion

$240,500
Susan M Kaech · Salk Institute For Biological Studies · R21 · FY2020 · AI

Understanding and Overcoming Resistance to Cancer Immunotherapy Due to Defective Antigen Presentation

$240,500
Katerina Abigail Politi · Yale University · R01 · FY2019 · CA

Molecular Imaging Reagents for Prostate Cancer Theranostics

$240,484
Zaver M Bhujwalla · Johns Hopkins University · P41 · FY2019 · EB

Molecular Imaging Reagents for Prostate Cancer Theranostics

$240,484
Zaver M Bhujwalla · Johns Hopkins University · P41 · FY2020 · EB